Protein
Protein (NP_001773)
CD72
B-cell differentiation antigen CD72 (Lyb-2) (CD antigen CD72)
CD72
CD72 molecule
Very low evidence
C-type lectin
Undefined
C-type - Natural Killer NK
a/b mixed / C-type lectin-like
MAEAITYADLRFVKAPLKKSISSRLGQDPGADDDGEITYENVQVPAVLGVPSSLASSVLGDKAAVKSEQPTASWRAVTSPAVGRILPCRTTCLRYLLLGLLLTCLLLGVTAICLGVRYLQVSQQLQQTNRVLEVTNSSLRQQLRLKITQLGQSAEDLQGSRRELAQSQEALQVEQRAHQAAEGQLQACQADRQKTKETLQSEEQQRRALEQKLSNMENRLKPFFTCGSADTCCPSGWIMHQKSCFYISLTSKNWQESQKQCETLSSKLATFSEIYPQSHSYYFLNSLLPNGGSGNSYWTGLSSNKDWKLTDDTQRTRTYAQSSKCNKVHKTWSWWTLESESCRSSLPYICEMTAFRFPD
No structure currently available in the PDB RCSB Databank.
Structural models
SWISS-MODEL structural models
The location of the lectin domain structural model is: 194-354
We infer [1.65, 2.18] Å as the interval of error of this structural model.
Template 1: 3WHD chain: C, Q8WXI8, NP_525126.2, sequence identity: 21.1%, coverage: 84.5%, location in sequence: 63-215, (63-215 in PDB).
Template 2: 6BBD chain: A, Q9N1X4, NP_999275.1, sequence identity: 17.4%, coverage: 86.3%, location in sequence: 225-378, (205-358 in PDB).
Template 3: 4WRE chain: A, P08427, NP_001257574.1, sequence identity: 14.3%, coverage: 80.7%, location in sequence: 108-248, (88-228 in PDB).
Show the alignment used for the construction of the structural model, Download.
Show the plot of DOPE energy score, Download.
We infer [1.65, 2.18] Å as the interval of error of this structural model.
Template 1: 3WHD chain: C, Q8WXI8, NP_525126.2, sequence identity: 21.1%, coverage: 84.5%, location in sequence: 63-215, (63-215 in PDB).
Template 2: 6BBD chain: A, Q9N1X4, NP_999275.1, sequence identity: 17.4%, coverage: 86.3%, location in sequence: 225-378, (205-358 in PDB).
Template 3: 4WRE chain: A, P08427, NP_001257574.1, sequence identity: 14.3%, coverage: 80.7%, location in sequence: 108-248, (88-228 in PDB).
Show the alignment used for the construction of the structural model, Download.
Show the plot of DOPE energy score, Download.
Ligand
Glycan ligands from structural data
No crystal structures of complexes with glycan ligand.
References
NCBI References (10 PubMed Identifiers)
- CD40 and CD72 expression and prognostic values among children with systemic lupus erythematosus: a case-control study. [32700598]
- A regulatory role for CD72 expression on B cells and increased soluble CD72 in primary Sjogren's syndrome. [32306893]
- A reference map of the human binary protein interactome. [32296183]
- Interferon-alpha-induced CD100 on naive CD8+ T cells enhances antiviral responses to hepatitis C infection through CD72 signal transduction. [28222623]
- Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritis. [26883681]
- The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. [9590210]
- Native soluble CD5 delivers a costimulatory signal to resting human B lymphocytes. [8806810]
- The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. [1711157]
- Identity of human Lyb-2 and CD72 and localization of the gene to chromosome 9. [2044654]
- Identification of a human protein homologous to the mouse Lyb-2 B cell differentiation antigen and sequence of the corresponding cDNA. [2141045]
UniProt Main References (1 PubMed Identifiers)
- The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). [15489334]
All isoforms of this gene containing a lectin domain
RNA
RNA (Transcript ID: NM_001782.3)
m7G-5')ppp(5'-GCAGUCACAGAGGGAACACAGAGCCUAGUUGUAAACGGACAGAGACGAGAGGGGCAAGGGAGGACAGUGGAUGACAGGGAAGACGAGUGGGGGCAGAGCUGCUCAGGACCAUGGCUGAGGCCAUCACCUAUGCAGAUCUGAGGUUUGUGAAGGCUCCCCUGAAGAAGAGCAUCUCCAGCCGGUUAGGACAGGACCCAGGGGCUGAUGAUGAUGGGGAAAUCACCUACGAGAAUGUUCAAGUGCCCGCAGUCCUAGGGGUGCCCUCAAGCUUGGCUUCUUCUGUACUAGGGGACAAAGCAGCGGUCAAGUCGGAGCAGCCAACUGCGUCCUGGAGAGCCGUGACGUCACCAGCUGUCGGGCGGAUUCUCCCCUGCCGCACAACCUGCCUGCGAUACCUCCUGCUCGGCCUGCUCCUCACCUGCCUGCUGUUAGGAGUGACCGCCAUCUGCCUGGGAGUGCGCUAUCUGCAGGUGUCUCAGCAGCUCCAGCAGACGAACAGGGUUCUGGAAGUCACUAACAGCAGCCUGAGGCAGCAGCUCCGCCUCAAGAUAACGCAGCUGGGACAGAGUGCAGAGGAUCUGCAGGGGUCCAGGAGAGAGCUGGCGCAGAGUCAGGAAGCACUACAGGUGGAACAGAGGGCUCAUCAGGCGGCCGAAGGGCAGCUACAGGCCUGCCAGGCAGACAGACAGAAGACGAAGGAGACCUUGCAAAGUGAGGAGCAACAGAGGAGGGCCUUGGAGCAGAAGCUGAGCAACAUGGAGAACAGACUGAAGCCCUUCUUCACAUGCGGCUCAGCAGACACCUGCUGUCCGUCGGGAUGGAUAAUGCAUCAGAAAAGCUGCUUUUACAUCUCACUUACUUCAAAAAAUUGGCAGGAGAGCCAAAAACAAUGUGAAACUCUGUCUUCCAAGCUGGCCACAUUCAGUGAAAUUUAUCCACAAUCACACUCUUACUACUUCUUAAAUUCACUGUUGCCAAAUGGUGGUUCAGGGAAUUCAUAUUGGACUGGCCUCAGCUCUAACAAGGAUUGGAAGUUGACUGAUGAUACACAACGCACUAGGACUUAUGCUCAAAGCUCAAAAUGUAACAAGGUACAUAAAACUUGGUCAUGGUGGACACUGGAGUCAGAGUCAUGUAGAAGUUCUCUUCCCUACAUCUGUGAGAUGACAGCUUUCAGGUUUCCAGAUUAGGACAGUCCUUUGCACUGAGUUGACACUCAUGCCAACAAGAACCUGUGCCCCUCCUUCCUAACCUGAGGCCUGGGGUUCCUCAGACCAUCUCCUUCAUUCUGGGCAGUGCCCAGCCACCGGCUGACCCACACCUGACACUUCCAGCCAGUCUGCUGCCUGCUCCCUCUUCCUGAAACUGGACUGUUCCUGGGAAAAGGGUGAAGCCACCUCUAGAAGGGACUUUGGCCUCCCCCCAAGAACUUCCCAUGGUAGAAUGGGGUGGGGGAGGAGGGCGCACGGGCUGAGCGGAUAGGGGCGGCCCGGAGCCAGCCAGGCAGUUUUAUUGAAAUCUUUUUAAAUAA-3'- Poly-A tail
- Coding region
DNA
DNA (Gene ID: 971)
CD72 molecule
strand -
LYB2, CD72b
NCBI CDS gene sequence (1080 bp)
5'-ATGGCTGAGGCCATCACCTATGCAGATCTGAGGTTTGTGAAGGCTCCCCTGAAGAAGAGCATCTCCAGCCGGTTAGGACAGGACCCAGGGGCTGATGATGATGGGGAAATCACCTACGAGAATGTTCAAGTGCCCGCAGTCCTAGGGGTGCCCTCAAGCTTGGCTTCTTCTGTACTAGGGGACAAAGCAGCGGTCAAGTCGGAGCAGCCAACTGCGTCCTGGAGAGCCGTGACGTCACCAGCTGTCGGGCGGATTCTCCCCTGCCGCACAACCTGCCTGCGATACCTCCTGCTCGGCCTGCTCCTCACCTGCCTGCTGTTAGGAGTGACCGCCATCTGCCTGGGAGTGCGCTATCTGCAGGTGTCTCAGCAGCTCCAGCAGACGAACAGGGTTCTGGAAGTCACTAACAGCAGCCTGAGGCAGCAGCTCCGCCTCAAGATAACGCAGCTGGGACAGAGTGCAGAGGATCTGCAGGGGTCCAGGAGAGAGCTGGCGCAGAGTCAGGAAGCACTACAGGTGGAACAGAGGGCTCATCAGGCGGCCGAAGGGCAGCTACAGGCCTGCCAGGCAGACAGACAGAAGACGAAGGAGACCTTGCAAAGTGAGGAGCAACAGAGGAGGGCCTTGGAGCAGAAGCTGAGCAACATGGAGAACAGACTGAAGCCCTTCTTCACATGCGGCTCAGCAGACACCTGCTGTCCGTCGGGATGGATAATGCATCAGAAAAGCTGCTTTTACATCTCACTTACTTCAAAAAATTGGCAGGAGAGCCAAAAACAATGTGAAACTCTGTCTTCCAAGCTGGCCACATTCAGTGAAATTTATCCACAATCACACTCTTACTACTTCTTAAATTCACTGTTGCCAAATGGTGGTTCAGGGAATTCATATTGGACTGGCCTCAGCTCTAACAAGGATTGGAAGTTGACTGATGATACACAACGCACTAGGACTTATGCTCAAAGCTCAAAATGTAACAAGGTACATAAAACTTGGTCATGGTGGACACTGGAGTCAGAGTCATGTAGAAGTTCTCTTCCCTACATCTGTGAGATGACAGCTTTCAGGTTTCCAGATTAG-3'
By using this site you agree to our privacy policy.
Please confirm you agree with the privacy policy before using the site.